Enantioselective Binaphthophosphepine-Promoted [3+2] Annulations
1
130.2 (d, JC,P = 79 Hz, C-P), 131.6 (d, JC,P = 2.7 Hz, CH), 131.9
NCH2CH=), 162.3 (CO2Et) ppm. 31P NMR (CDCl3, 121 MHz): δ
= 26 ppm. MS (ESI): m/z = 490 [M + Na]+. HPLC: Chiracel AD
3
(d, JC,P = 2.6 Hz, CH), 132.4, 132.5, 137.0 (d, JC,P = 5.1 Hz,
NCH2CH=), 137.6 (d, JC,P = 5.4 Hz, C), 142.4 (d, JC,P = 2.6 Hz, heptane/iPrOH (80:20), 1 mL/min, tR = 11.0 min for the (R) enanti-
C), 162.2 (CO2Et) ppm. 31P NMR (CDCl3, 121 MHz): δ = 26 ppm. omer, tR = 16.8 min for the (S) enantiomer.
MS (ESI): m/z = 440 [M + Na]+. HPLC: Chiracel AD, heptane/
Cyclohexyl 1-(Diphenylphosphinoyl)-2,5-dihydro-2-(1-naphthyl)pyr-
iPrOH (80:20), 1 mL/min, tR = 7.5 min for the (R) enantiomer, tR
role-3-carboxylate (4b): Purification of 4b was performed by col-
= 8.5 min for the (S) enantiomer. [α]2D0 = +126 (c = 1, CHCl3, 75%
umn chromatography with heptanes/EtOAc (3:7) as the eluent (Rf
ee).
= 0.2). Colourless oil. 1H NMR (CDCl3, 300 MHz): δ = 0.6–1.6
Pyrroline 3a slowly converted into the corresponding pyrrole when
stored at r.t. An authentic sample of ethyl 1-(diphenylphosphinoyl)-
2-phenylpyrrole-3-carboxylate was obtained by the DDQ oxi-
dation[20] of 3a: 1H NMR (CDCl3, 300 MHz): δ = 0.94 (t, J =
(10 H), 4.2–4.5 (m, 2 H, NCH2), 6.37 (br., 1 H, NCH), 6.7 (2 H),
6.8 (2 H), 7.1 (1 H), 7.2–7.3 (8 H), 7.5 (3 H), 7.7 (2 H) ppm. 13C
NMR (CDCl3, 75 MHz): δ = 23.4 (CH2), 23.5 (CH2), 25.0 (CH2),
30.7 (CH2), 31.2 (CH2), 54.9 (NCH2), 73.0 (OCH), 123.2, 124.9,
125.0, 125.5, 127.4, 127.6, 128.0, 128.5, 128.7, 131.1 (d), 131.8 (d),
7.2 Hz, 3 H, Me), 3.96 (q, J = 7.2 Hz, 2 H, OCH2), 6.49 (t, JH,H
≈
3
JH,P = 3.6 Hz, 1 H), 6.64 (t, JH,H ≈ JH,P = 3.0 Hz, 1 H), 6.9–7.1 (5
132.2, 132.3, 136.7 (d, JC,P = 4.6 Hz, NCH2CH=), 161.8 (CO2Cy)
H), 7.3–7.4 (4 H), 7.4–7.5 (6 H) ppm. 13C NMR (CDCl3, 75 MHz): ppm. 31P NMR (CDCl3, 121 MHz): δ = 27 ppm. MS (ESI): m/z =
δ = 13.9 (Me), 59.7 (OCH2), 111.9 (d, JC,P = 7.4 Hz, CH), 119.4
(d, JC,P = 6.3 Hz, C), 124.6 (d, JC,P = 5.9 Hz, CH), 126.7, 128.0,
544 [M + Na]+. HPLC: Chiracel AD, heptane/iPrOH (85:15),
1 mL/min, tR = 10.4 min for the (R) enantiomer, tR = 13.6 min for
128.5, 128.7, 128.9 (C), 129.0 (C), 130.7 (C), 131.7, 131.96, 132.10, the (S) enantiomer.
132.80, 132.83, 142.6 (d, JC,P = 7.4 Hz, C), 164.1 (CO2Et) ppm. 31
P
Ethyl 1-(Diphenylphosphinoyl)-2,5-dihydro-2-(2-vinylphenyl)pyrrole-
3-carboxylate (3c): Compound 3c was purified by chromatography
on TLC plates (silica gel) with heptanes/EtOAc (3:7) as the eluent.
NMR (CDCl3, 121 MHz): δ = 25 ppm. MS (ESI): m/z = 438 [M
+ Na]+.
Cyclohexyl 1-(Diphenylphosphinoyl)-2,5-dihydro-2-phenylpyrrole-3- 1H NMR (CDCl3, 500 MHz): δ = 1.07 (t, J = 7.0 Hz, 3 H, Me),
carboxylate (4a): The purification of 4a was performed by column
3.97 (m, 2 H, OCH2), 4.29 (dt, 2J = 17.0, 5.5 Hz, 1 H, NCH2), 4.43
(br. dd, 2J ≈ 17 Hz, 1 H, NCH2), 4.96 (d, 3J = 11.0 Hz, 1 H, =CH2),
chromatography with a heptane/EtOAc gradient (40:60 to 0:100)
1
3
as the eluent (Rf = 0.2, EtOAc). Colourless oil. H NMR (CDCl3,
5.19 (d, J = 17.5 Hz, 1 H, =CH2), 5.99 (m, 1 H, NCH), 6.60 (dd,
500 MHz): δ = 1.1–1.7 (10 H), 4.29 (dt, J = 17.5, 4.5 Hz, 1 H, 3J = 17.5, 11.0 Hz, 1 H, =CHAr), 6.89 (s, 1 H, NCH2CH=), 7.1–
NCH2), 4.39 (dd, J = 17.5, 11.0 Hz, 1 H, NCH2), 4.61 (m, 1 H, 7.5 (12 H), 7.8 (2 H) ppm. 13C NMR (CDCl3, 75 MHz): δ = 13.9
2
OCH), 5.52 (m, 1 H, NCH), 6.85 (3 H), 7.108 (3 H), 7.19 (2 H), (Me), 55.1 (d, JC,P = 2.6 Hz, NCH2), 60.5 (OCH2), 63.6 (NCH),
7.3–7.5 (4 H), 7.55 (2 H), 7.81 (2 H) ppm. 13C NMR (CDCl3,
115.7 (=CH2), 125.7, 127.4, 127.7, 127.9, 128.1, 128.6, 128.7, 129.1
75 MHz): δ = 23.3 (CH2), 23.5 (CH2), 25.2 (CH2), 31.0 (CH2), 31.4 (C), 130.8 (C), 131.1 (C), 131.6 (d, JC,P = 2.6 Hz, CH), 131.9 (d,
2
2
(CH2), 54.7 (d, JC,P = 2.9 Hz, NCH2), 68.2 (d, JC,P = 3.3 Hz, JC,P = 2.6 Hz, CH), 132.1, 132.3, 132.5, 132.6, 132.8 (C), 133.9
3
NCH), 73.0 (OCH), 126.7, 127.1, 127.4, 127.8, 128.0, 128.1, 128.5,
(=CHPh), 136.9 (C), 137.2 (d, JC,P = 4.8 Hz, NCH2CH=), 137.8
1
130.2 (d, JC,P = 81 Hz, C-P), 131.5 (d, JC,P = 2.6 Hz, CH), 131.9
(C), 137.9 (C), 139.9 (C), 162.2 (CO2Et) ppm. 31P NMR (CDCl3,
(d, JC,P = 2.5 Hz, CH), 132.35, 132.40, 132.47, 132.53, 137.0 (d, 121 MHz): δ = 27 ppm. HRMS: calcd. for C27H26NNaO3P
3JC,P = 5.1 Hz, NCH2CH=),138.0 (d, JC,P = 5.6 Hz, C), 142.4 (d,
JC,P = 2.4 Hz, C), 161.7 (CO2Cy) ppm. 31P NMR (CDCl3,
121 MHz): δ = 27 ppm. HPLC: Chiracel AD, heptane/iPrOH
466.1548; found 466.1553. HPLC: Chiracel AD, heptane/iPrOH
(80:20), 1 mL/min, tR = 6.7 min for the major (R) enantiomer, tR
= 9.7 min for the (S) enantiomer.
(80:20), 1 mL/min, tR = 6.6 min for the (R) enantiomer, tR
8.8 min for the (S) enantiomer.
=
Ethyl 1-(Diphenylphosphinoyl)-2,5-dihydro-2-(2-styryl)pyrrole-3-car-
boxylate (3d): Purification of 3d was performed by column
chromatography on alumina with heptanes/EtOAc (1:1) as the elu-
ent. 1H NMR (CDCl3, 300 MHz): δ = 1.14 (t, J = 7.2 Hz, 3 H,
Me), 4.0–4.2 (m, 4 H, OCH2 + NCH2), 5.04 (m, 1 H, NCH), 5.78
Pyrroline 4a slowly dehydrogenated into the corresponding pyrrole.
An authentic sample of cyclohexyl 1-(diphenylphosphinoyl)-2-
phenylpyrrole-3-carboxylate was obtained by the DDQ oxidation
of 4a: 1H NMR (CDCl3, 500 MHz): δ = 1.0–1.6 (10 H), 4.66 (d, JA,B = 15.6 Hz, 1 H, =CHPh), 5.91 (dd, J = 15.6, 7.8 Hz, 1
3
3
(OCH), 6.55 (t, J = 3.5 Hz, 1 H, CH), 6.72 (t, J = 3.0 Hz, 1 H,
H, CH=CHPh), 6.74 (s, 1 H, NCH2CH=), 7.0–7.9 (Ph) ppm. 13C
CH), 6.98–7.05 (4 H), 7.1 (1 H), 7.4 (4 H), 7.5–7.6 (6 H) ppm. 13C NMR (CDCl3, 75 MHz): δ = 14.1 (Me), 53.6 (NCH2), 60.4
NMR (CDCl3, 125 MHz): δ = 23.2 (CH2), 25.3 (CH2), 31.2 (CH2), (OCH2), 66.9 (NCH), 126.6, 127.5, 128.1–128.7, 131.6, 131.9–
2
2
71.9 (OCH), 112.0 (d, JC,P = 7.4 Hz, NCH), 120.0 (d, JC,P
=
132.1, 132.5, 132.6, 132.7, 136.0 (d, JC,P = 5.6 Hz, C), 136.6 (C),
6.0 Hz, C), 124.5 (d, 3JC,P = 5.7 Hz, CH), 126.7, 128.0, 128.6, 128.7,
129.4 (C), 130.4 (C), 131.2 (C), 131.7, 132.0, 132.1, 132.8, 142.2 (d,
JC,P = 4.3 Hz, C), 163.7 (CO2Cy) ppm. 31P NMR (CDCl3,
121 MHz): δ = 22 ppm.
137.9 (d, JC,P = 5.6 Hz, NCH2CH=), 162.4 (CO2Et) ppm. 31P
3
NMR (CDCl3, 121 MHz): δ = 26 ppm. HRMS: calcd. for
C27H26NNaO3P 466.1548; found 466.1539.
Ethyl 2-(3-Bromophenyl)-1-(diphenylphosphinoyl)-2,5-dihydropyr-
Ethyl 1-(Diphenylphosphinoyl)-2,5-dihydro-2-(1-naphthyl)pyrrole-3- role-3-carboxylate (3e): Purification of 3e was performed by col-
carboxylate (3b): Purification of 3b was performed by column
umn chromatography on silica gel with EtOAc as the eluent. 1H
chromatography on silica gel with heptanes/EtOAc (3:7) as the elu-
NMR (CDCl3, 500 MHz): δ = 1.11 (t, J = 7.0 Hz, 3 H, Me), 3.9–
ent (Rf = 0.2). Colourless oil. 1H NMR (CDCl3, 300 MHz): δ = 4.1 (m, 2 H, OCH2), 4.31 (dm, 2J = 17.1, J = 7, 5, 1.9 Hz, 1 H,
2
0.81 (t, J = 7.2 Hz, 3 H, Me), 3.82 (q, J = 7.2 Hz, 2 H, OCH2), NCH2), 4.42 (dm, J = 17, J = 11 Hz, 1 H, NCH2), 5.47 (m, 1 H,
4.40 (dm, J = 17.1 Hz, 1 H, NCH2), 4.47 (m, 1 H, NCH2), 6.42 NCH), 6.84 (t, J = 1.5 Hz, 1 H), 6.87 (d, J = 8.0 Hz, 1 H), 6.91 (s,
(br., 1 H, NCH), 6.7 (2 H), 6.9 (2 H), 7.1 (1 H), 7.2–7.4 (8 H), 7.6 1 H), 7.0 (t, J = 7.5 Hz, 1 H), 7.2–7.3 (3 H), 7.4–7.5 (3 H), 7.5–7.6
(3 H), 7.7 (2 H) ppm. 13C NMR (CDCl3, 75 MHz): δ = 13.6 (Me),
(3 H), 7.8 (2 H) ppm. 13C NMR (CDCl3, 75 MHz): δ = 13.9 (Me),
54.8 (NCH2), 60.5 (OCH2), 123.16, 124.95, 125.07, 125.44, 127.50, 54.7 (NCH2), 60.9 (OCH2), 68.1 (NCH), 122.0 (C), 126.1, 128.1,
127.67, 128.02, 128.49, 128.66, 131.2 (d, JC,P = 2 Hz, CH), 131.8 (d, 128.3, 128.6, 128.8, 129.5, 130.3, 130.6, 131.9–132.5, 136.8 (C),
3
3
JC,P = 2 Hz, CH), 132.10, 132.22, 132.34, 136.8 (d, JC,P = 5.0 Hz,
137.7 (d, JC,P = 4.7 Hz, NCH2CH=), 144.7 (C), 162.2 (CO2Et)
Eur. J. Org. Chem. 2009, 146–151
© 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
149